Sandeep Kumar: A Second Chance for a Child with Fanconi Anemia
Sandeep Kumar, Assistant Manager – Program at The Hans Foundation, shared Srivatsan Rangachari’s post on LinkedIn:
“Being part of the Hans Paediatric Program (HPP), I have seen how access to timely and specialized healthcare can change the course of a child’s life.
This story of a 12 year old girl battling Fanconi anemia and undergoing a life saving stem cell transplant, with her younger sister as the matched sibling donor, is truly moving.
Behind every treatment is a family hoping for a second chance.
Supporting such cases reminds us why our work matters ensuring that financial constraints do not stand between a child and the treatment they urgently need.
Grateful to the medical team at GKNM Hospital, Coimbatore, and proud that through The Hans Foundation, HPP could support this child and her family during such a critical journey.
Wishing her strength, good health, and a bright future ahead.”
Srivatsan Rangachari, Chief of Resource Mobilization and Community Initiatives at KNC Trust, Program Manager, Pediatric Cardiology at Genesis Foundation, shared a post on LinkedIn:
“A 12 year old girl diagnosed with Fanconi anemia, a rare inherited blood disorder, recently underwent an allogeneic hematopoietic stem cell transplant at GKNM Hospital Coimbatore, with her three year old younger sister as the matched sibling donor.
The child had been experiencing a progressive decline in her blood cell counts and required repeated blood transfusions.
Detailed evaluation confirmed Fanconi anemia with bone marrow failure, necessitating stem cell transplantation.
For families facing rare and complex disorders, access to specialized treatment can also bring a significant financial burden.
We are deeply grateful to The Hans Foundation for covering the full cost of her treatment, enabling the family to access this lifesaving care without financial constraints becoming a barrier.
The child’s journey and treatment at GKNM have been featured in The Hindu, both in its print and online editions.
Such coverage helps create greater awareness about rare blood disorders and the possibilities offered by timely diagnosis, specialized care and stem cell transplantation.
Our sincere appreciation to the entire clinical team involved in her treatment and to The Hans Foundation for continuing to support children and families who need specialized care.
Every child deserves access to the right treatment, at the right time.”
Stay updated with Hemostasis Today.
-
Oct 7, 2026, 02:41Kemal Karaagac: Optimising DOAC Resumption After Major Bleeding in Atrial Fibrillation
-
Oct 7, 2026, 02:21Joseph Aslan: mPTP Inhibition Targets Platelet Procoagulant Activity and Thrombosis
-
Oct 7, 2026, 02:07Manuel Monreal: ECG Improves Risk Stratification in Acute Pulmonary Embolism
-
Oct 6, 2026, 22:43Alessandra Bosch: Pediatric GTH Opens with Regional Experts Convening on Pediatric Hemostasis and Thrombosis
-
Oct 6, 2026, 22:39Managing Thrombotic Risk in Pregnancy – How the Lab May Help – Sysmex Europe
-
Oct 6, 2026, 22:33Ahmet Davut Aksu: A Multi-Objective Approach to Enhance Fibrinolysis, Selectivity, and Inhibition Resistance
-
Oct 6, 2026, 22:29Muhammad Abubakar: New Study on Iron Biology to Be Presented at ASH 2026 and Published in Blood
-
Oct 6, 2026, 22:24David McIntosh: Calling On Decision-Makers to Prioritize Donors and Clinical Access During IPAW 2026
-
Oct 6, 2026, 22:21Zoltan Nagy: With All Eyes on Optogenetics Today, What Can It Do in Megakaryocytes and Platelets?